Anjali Geethadevi
5PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 05, 2024
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer.Anjali Geethadevi, Zhiqiang Ku, Shirng-Wern Tsaih
|Aug 12, 2021
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth.Anjali Geethadevi, Ajay Nair, Deepak Parashar
|Mar 03, 2021
Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L/CRR9-mediated chemotherapeutic drug resistance.Deepak Parashar, Anjali Geethadevi, Donna McAllister
|Oct 22, 2020
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.Deepak Parashar, Bindu Nair, Anjali Geethadevi
|Jun 24, 2019
Betaine accumulation suppresses the de-novo synthesis of ectoine at a low osmotic concentration in Halomonas sp SBS 10, a bacterium with broad salinity tolerance.Bijayendra Kushwaha, Indrani Jadhav, Hriday Narain Verma
Pageof 1
Frequent Collaborators
5 joint publications
Deepak Parashar
3 joint publications
Bindu Nair
3 joint publications
Pradeep Chaluvally-Raghavan
2 joint publications
Shirng-Wern Tsaih
2 joint publications
Janet S Rader
2 joint publications
Sunila Pradeep
1 joint publications
Bijayendra Kushwaha
1 joint publications
Indrani Jadhav
1 joint publications
Kapilesh Jadhav
1 joint publications
Zhiqiang An
